TSE:ACB - Aurora Cannabis Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$8.02 +0.05 (+0.63 %)
(As of 07/18/2018 02:32 PM ET)
Previous CloseC$7.97
Today's RangeC$7.87 - C$8.17
52-Week RangeC$2.35 - C$15.20
Volume4.89 million shs
Average Volume13.54 million shs
Market CapitalizationC$5.37 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aurora Cannabis Inc., together with its subsidiaries, produces and distributes medical marijuana products in Canada. The company's products consist of dried cannabis and cannabis oil. It also operates as a pharmaceutical wholesaler and narcotics dealer of medical marijuana in Germany and the European Union; and produces and sells proprietary systems for the indoor cultivation of cannabis, organic microgreens, vegetables, and herbs. In addition, the company provides counseling and outreach service to help patients learn about how to safely and effectively use medical cannabis; select a strain from the available in Canada; and register with their choice of licensed producer. Further, it engages in the business of consulting on the design, engineering, and construction oversight for advanced greenhouse cultivation facilities. The company has a strategic agreement with Capcium Inc. Aurora Cannabis Inc. is headquartered in Vancouver, Canada.

Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolTSE:ACB
CUSIPN/A
Phone+1-604-3625207

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins61.49%
Return on Equity7.80%
Return on Assets5.34%

Miscellaneous

EmployeesN/A
Outstanding Shares564,966,000
Market CapC$5,370.00

The Truth About Cryptocurrencies

Aurora Cannabis (TSE:ACB) Frequently Asked Questions

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc (TSE:ACB) released its earnings results on Tuesday, May, 8th. The company reported ($0.05) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.02) by $0.03. The company earned $16.10 million during the quarter, compared to the consensus estimate of $20.30 million. Aurora Cannabis had a return on equity of 7.80% and a net margin of 61.49%. View Aurora Cannabis' Earnings History.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release their next quarterly earnings announcement on Tuesday, September, 25th 2018. View Earnings Estimates for Aurora Cannabis.

What price target have analysts set for ACB?

1 brokers have issued 12 month target prices for Aurora Cannabis' stock. Their predictions range from C$11.00 to C$11.00. On average, they expect Aurora Cannabis' stock price to reach C$11.00 in the next year. This suggests a possible upside of 36.8% from the stock's current price. View Analyst Ratings for Aurora Cannabis.

What is the consensus analysts' recommendation for Aurora Cannabis?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Aurora Cannabis' key competitors?

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the folowing people:
  • Mr. Terry Booth, Founder, CEO & Director (Age 53)
  • Mr. Stephen Dobler, Founder, Pres & Director (Age 53)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren, Chief Operational Officer
  • Dr. Jason Ronald Bradley Dyck Ph.D., Head of Research Council & Director

Has Aurora Cannabis been receiving favorable news coverage?

Media coverage about ACB stock has been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Aurora Cannabis earned a media sentiment score of 0.11 on Accern's scale. They also gave press coverage about the company an impact score of 44.72 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Aurora Cannabis?

Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately C$8.04.

How big of a company is Aurora Cannabis?

Aurora Cannabis has a market capitalization of C$5.37 billion.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.


MarketBeat Community Rating for Aurora Cannabis (TSE ACB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.